Recruiting NA Lung Diseases

Compares treatment options for Lung Diseases

Official title PET/CT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS

ClinicalTrials.gov ID: NCT06923098

What this study is testing

What it's testing
Percutaneous CT guided biopsy is a well-established, standard sampling technique for suspected neoplastic lesions located in peripheral region in lung parenchyma. Inconclusive results on CT guided biopsy is substantially higher in large lung lesions which are prone to cause peripheral pneumonia, atelectasis and even regional necrosis, which are hard to be distinguished from tumor on CT images.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Age above 18 years
  • INR \ 80,000/mm3
  • CT thorax with lung lesion more than 10 mm.
  • Accessible lesions for CT-guided biopsy.

You likely can't join if

  • Participants with pre-existing bleeding diathesis like hemophilia, coagulopathy defined by -INR ≥1.2 and Platelet counts ≤ 80,000/mm3
  • Participants who refuse to provide consent
  • Signs of hypoperfusion like hypotension, cyanosis etc.
  • Presence of hypoxemia with SpO2 \< 94 %- measured in a pulse oximeter)
  • Pregnant/Lactating female people
  • Non-cooperative people
See the full eligibility criteria
Who can join
  • Age above 18 years
  • INR \ 80,000/mm3
  • CT thorax with lung lesion more than 10 mm.
  • Accessible lesions for CT-guided biopsy.
What rules you out
  • Participants with pre-existing bleeding diathesis like hemophilia, coagulopathy defined by -INR ≥1.2 and Platelet counts ≤ 80,000/mm3
  • Participants who refuse to provide consent
  • Signs of hypoperfusion like hypotension, cyanosis etc.
  • Presence of hypoxemia with SpO2 \< 94 %- measured in a pulse oximeter)
  • Pregnant/Lactating female people
  • Non-cooperative people
  • Lesions that are inaccessible (decision made on pre-biopsy planning)
  • Serum creatinine level more than 2mg/dl.

The study team makes the final eligibility decision.

Where it's taking place

  • Bhubaneswar, Odisha, India

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Bhubaneswar, Odisha, India. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.